FIELD: medicine, allergology, pharmacy. SUBSTANCE: invention relates to drugs eliciting antiallergic, antiasthmatic and anti-inflammatory actions. Invention proposes to use the hepatoprotecting agent of the formula (I)
as an antiallergic and anti-inflammatory agent. EFFECT: lowered toxicity of agent. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIALLERGENIC AND ANTIINFLAMMATORY AGENT | 1999 |
|
RU2160097C1 |
| 2-HYDROXY-3-METHOXYBENZALDEHYDE ISONICOTINOYL HYDRAZONE SHOWING ANTIASTHMATIC, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITY | 1997 |
|
RU2139711C1 |
| 5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
| PHARMACEUTICAL COMPOSITION WITH ANTI-ALLERGIC AND ANTI-INFLAMMATORY ACTION | 2006 |
|
RU2308272C1 |
| MONO- OR DICARBOXYLIC ACID ZINC SALTS SHOWING GASTROPROTECING ACTIVITY | 1995 |
|
RU2116292C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTIINFLAMMATORY, BRONCHOLYTIC, ANTI-TUBERCULOSIS ACTIVITY | 2011 |
|
RU2448961C1 |
| AGENT SHOWING ANTIASTHMATIC AND ANTIADHESION EFFECT | 1997 |
|
RU2117482C1 |
| DERIVATIVES OF 2-(3,4-DIHYDROXYPHENYL) ETHYLAMINE SHOWING IMMUNOTROPIC ACTIVITY AND CAPABILITY TO INHIBIT VIRUS REPLICATION | 1992 |
|
RU2039733C1 |
| INHALATION COMPOSITION FOR BRONCHIAL ASTHMA TREATMENT | 1992 |
|
RU2054932C1 |
| PREPARATION FOR TUBERCULOSIS TREATMENT | 1994 |
|
RU2080114C1 |
Authors
Dates
2001-07-10—Published
1999-07-27—Filed